Page last updated: 2024-09-04
docetaxel anhydrous and Lymphoma, Large B-Cell, Diffuse
docetaxel anhydrous has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Fan, J; Li, H; Li, Y; Ouyang, J; Wang, J; Wu, L; Zhang, Z; Zuo, L | 1 |
Other Studies
1 other study(ies) available for docetaxel anhydrous and Lymphoma, Large B-Cell, Diffuse
Article | Year |
---|---|
Development of taxane-containing chemotherapy of doxorubicin-resistant diffuse large B-cell lymphoma.
Topics: Antineoplastic Agents; Apoptosis; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lymphoma, Large B-Cell, Diffuse; Paclitaxel; Taxoids; Tumor Cells, Cultured | 2014 |